Mehmet Uzumcu
Chief Scientific & Technology Officer
Gilbert Technologies
Gilbert Technologies develops a Smart Precision Inhaler utilizing proprietary electrospray technology for the precise pulmonary delivery of medications. This device addresses the challenge of effectively treating patients with difficult-to-manage lung conditions by optimizing aerosol generation for advanced pharmaceutical compounds.
- Biotechnology
- Hardware
- Healthcare Technology
- Medical Devices
Updated 7 months ago
Funding
Funding rounds are not available yet.
Founders
Product
Problem
Many patients with lung conditions struggle to manage their symptoms effectively due to limitations in existing inhaler technologies. Current devices often fail to deliver medication precisely to the targeted areas of the lungs, leading to suboptimal treatment outcomes. This is especially problematic for advanced pharmaceutical compounds requiring accurate and efficient pulmonary delivery.
Solution
Gilbert Technologies is developing a Smart Precision Inhaler that utilizes proprietary electrospray technology to improve the pulmonary delivery of medications. The device employs Electro Hydrodynamic Atomization (EHDA) to generate a monodispersed aerosol with customizable droplet sizes, enabling precise targeting of drugs to specific regions within the lungs. This approach aims to enhance the efficacy and safety of inhaled treatments by optimizing aerosol generation for both small and large molecule therapies in solution and suspension formulations. The breath-actuated inhaler creates a soft mist, potentially improving drug delivery and therapy adherence for patients.
Target Audience
The primary target audience includes pharmaceutical and biotech companies developing innovative inhaled treatments, as well as patients with difficult-to-treat lung conditions who require more precise and effective drug delivery.
Features
- Electrospray technology based on Electro Hydrodynamic Atomization (EHDA) for aerosol generation
- Customizable droplet size for targeted drug delivery to specific lung regions
- Compatibility with both small and large molecule therapies
- Suitable for solution and suspension formulations
- Breath-actuated mechanism for ease of use
- Monodispersed aerosol for efficient and consistent drug delivery